Related Experiment Videos
Should there be mass screening using faecal occult blood tests for colorectal cancer?
1Registre des Tumeurs Digestives (Equipe associée INSERM-DGS and CRI 9505), Faculté de Médecine, Dijon, France.
European Journal of Cancer (Oxford, England : 1990)
|November 3, 1998
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A need to simplify informed consent documents in cancer clinical trials. A position paper of the ARCAD Group.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
How health-related quality of life assessment should be used in advanced colorectal cancer clinical trials.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Differential diagnosis of adnexal masses: sequential use of the risk of malignancy index and HistoScanning, a novel computer-aided diagnostic tool.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2011
Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015.
Annals of oncology : official journal of the European Society for Medical Oncology·2007
Lenvatinib plus pembrolizumab for the treatment of patients with non-BRAF mutated anaplastic thyroid cancer: A single center, phase 2 clinical trial.
European journal of cancer (Oxford, England : 1990)·2026
Older adults with resectable gastric cancer undergoing perioperative chemotherapy or preoperative chemoradiotherapy plus perioperative chemotherapy: A secondary analysis of the AGITG TOPGEAR phase III trial.
European journal of cancer (Oxford, England : 1990)·2026
Diagnostic regulatory pathways are an underrecognized bottleneck in precision oncology clinical trials: Real-world evidence across Europe.
European journal of cancer (Oxford, England : 1990)·2026
Hypomethylating agents with venetoclax for newly diagnosed acute myeloid leukemia in patients 65 and older in The Netherlands - A nationwide study of drug usage and treatment outcomes.
European journal of cancer (Oxford, England : 1990)·2026
Spectral cytometry-based immune profiling coupled with machine learning identifies circulating Th1-like cells as a blood biomarker for advanced colorectal adenomas.
European journal of cancer (Oxford, England : 1990)·2026
Systemic therapies for gastroenteropancreatic neuroendocrine carcinomas: Current paradigm and future avenues.
European journal of cancer (Oxford, England : 1990)·2026